• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相互作用:INSM1与N-Myc在侵袭性神经母细胞瘤中的重要作用

Interplay: The Essential Role between INSM1 and N-Myc in Aggressive Neuroblastoma.

作者信息

Chen Chiachen, Lan Michael S

机构信息

Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

出版信息

Biology (Basel). 2022 Sep 20;11(10):1376. doi: 10.3390/biology11101376.

DOI:10.3390/biology11101376
PMID:36290282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9598261/
Abstract

An aggressive form of neuroblastoma (NB), a malignant childhood cancer derived from granule neuron precursors and sympathoadrenal lineage, frequently comprises amplification/elevated N-Myc expression, which contributes to the development of neural crest-derived embryonal malignancy. N-Myc is an oncogenic driver in NB. Persistent N-Myc expression during the maturation of SA precursor cells can cause blockage of the apoptosis and induce abnormal proliferation, resulting in NB development. An insulinoma-associated-1 (INSM1) zinc-finger transcription factor has emerged as an NB biomarker that plays a critical role in facilitating tumor cell growth and transformation. INSM1 plays an essential role in sympathoadrenal cell differentiation. N-Myc activates endogenous INSM1 through an of the proximal promoter, whereas INSM1 enhances N-Myc stability via RAC-α-serine/threonine protein kinase (AKT) phosphorylation in NB. The ectopic expression of INSM1 stimulates NB tumor growth in contrast to the knockdown of INSM1 that inhibits NB cell proliferation. The clinical pathological result and bioinformatics analysis show that INSM1 is a strong diagnostic and a prognostic biomarker for the evaluation of NB progression. The INSM1/N-Myc expression shows high clinical relevance in NB. Therefore, targeting the INSM1/N-Myc-associated signaling axis should be a feasible approach to identifying new drugs for the suppression of NB tumor growth.

摘要

神经母细胞瘤(NB)是一种侵袭性的儿童恶性肿瘤,起源于颗粒神经元前体和交感肾上腺谱系,常伴有N-Myc基因扩增/表达升高,这促使神经嵴来源的胚胎性恶性肿瘤发展。N-Myc是NB中的致癌驱动因子。在交感肾上腺(SA)前体细胞成熟过程中持续的N-Myc表达可导致细胞凋亡受阻并诱导异常增殖,从而引发NB。胰岛素瘤相关蛋白1(INSM1)锌指转录因子已成为一种NB生物标志物,在促进肿瘤细胞生长和转化中起关键作用。INSM1在交感肾上腺细胞分化中起重要作用。N-Myc通过近端启动子的 激活内源性INSM1,而在NB中INSM1通过RAC-α-丝氨酸/苏氨酸蛋白激酶(AKT)磷酸化增强N-Myc的稳定性。与抑制NB细胞增殖的INSM1敲低相反,INSM1的异位表达刺激NB肿瘤生长。临床病理结果和生物信息学分析表明,INSM1是评估NB进展的强有力的诊断和预后生物标志物。INSM1/N-Myc表达在NB中显示出高度的临床相关性。因此,靶向INSM1/N-Myc相关信号轴应该是一种可行的方法来确定抑制NB肿瘤生长的新药。 (注:原文中“An insulinoma-associated-1 (INSM1) zinc-finger transcription factor has emerged as an NB biomarker that plays a critical role in facilitating tumor cell growth and transformation.”一句中“through an of the proximal promoter”部分缺失关键信息,翻译可能存在不准确之处。)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/190cf7bfd52a/biology-11-01376-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/6c0e39dbb1d1/biology-11-01376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/68c8346b6714/biology-11-01376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/8da335b81215/biology-11-01376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/ccbfc2f6cdd5/biology-11-01376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/190cf7bfd52a/biology-11-01376-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/6c0e39dbb1d1/biology-11-01376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/68c8346b6714/biology-11-01376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/8da335b81215/biology-11-01376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/ccbfc2f6cdd5/biology-11-01376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6060/9598261/190cf7bfd52a/biology-11-01376-g005.jpg

相似文献

1
Interplay: The Essential Role between INSM1 and N-Myc in Aggressive Neuroblastoma.相互作用:INSM1与N-Myc在侵袭性神经母细胞瘤中的重要作用
Biology (Basel). 2022 Sep 20;11(10):1376. doi: 10.3390/biology11101376.
2
Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in N-Myc-activated neuroblastoma.植物生物碱高三尖杉酯碱靶向 N-Myc 激活神经母细胞瘤中的胰岛素瘤相关蛋白 1。
Cell Signal. 2023 Sep;109:110753. doi: 10.1016/j.cellsig.2023.110753. Epub 2023 Jun 9.
3
A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma.一种基于启动子驱动的 INSM1 相关信号通路在神经母细胞瘤中的检测方法。
Cell Signal. 2020 Dec;76:109785. doi: 10.1016/j.cellsig.2020.109785. Epub 2020 Sep 20.
4
5'-Iodotubercidin represses expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth.5'-碘尿苷抑制 表达,降低 cAMP 水平,并抑制人神经母细胞瘤细胞生长。
J Biol Chem. 2019 Apr 5;294(14):5456-5465. doi: 10.1074/jbc.RA118.006761. Epub 2019 Feb 12.
5
Small Molecules Targeting INSM1 for the Treatment of High-Risk Neuroblastoma.靶向INSM1治疗高危神经母细胞瘤的小分子药物
Biology (Basel). 2023 Aug 15;12(8):1134. doi: 10.3390/biology12081134.
6
Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer. Sonic hedgehog 信号通路促进神经内分泌肺癌中的 INSM1 转录因子。
Cell Signal. 2018 Jun;46:83-91. doi: 10.1016/j.cellsig.2018.02.014. Epub 2018 Mar 1.
7
INSM1 increases N-myc stability and oncogenesis via a positive-feedback loop in neuroblastoma.在神经母细胞瘤中,INSM1通过正反馈回路增加N-myc的稳定性并促进肿瘤发生。
Oncotarget. 2015 Nov 3;6(34):36700-12. doi: 10.18632/oncotarget.5485.
8
Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.MYCN和活化的ALK信号传导促进胚胎交感神经母细胞的增殖与存活。
J Neurosci. 2016 Oct 5;36(40):10425-10439. doi: 10.1523/JNEUROSCI.0183-16.2016.
9
Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development.在神经母细胞瘤中具有预后价值的c-MYC和MYCN的靶基因在交感肾上腺发育过程中表现出不同的表达。
Cancers (Basel). 2023 Sep 16;15(18):4599. doi: 10.3390/cancers15184599.
10
Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics.胰岛素瘤相关蛋白 1:从神经内分泌肿瘤标志物到癌症治疗策略。
Mol Cancer Res. 2019 Aug;17(8):1597-1604. doi: 10.1158/1541-7786.MCR-19-0286. Epub 2019 May 21.

引用本文的文献

1
Regulatory roles of insulin growth factor binding protein family in neuroblastoma cell proliferation and differentiation: Potential prognostic biomarkers and therapeutic targets for neuroblastoma.胰岛素生长因子结合蛋白家族在神经母细胞瘤细胞增殖和分化中的调控作用:神经母细胞瘤潜在的预后生物标志物和治疗靶点
Pediatr Discov. 2024 Jun 8;2(3):e68. doi: 10.1002/pdi3.68. eCollection 2024 Sep.
2
High-risk neuroblastoma in Mexico: from multimodal treatment to immunotherapy. Regarding the first case treated with naxitamab.墨西哥的高危神经母细胞瘤:从多模式治疗到免疫疗法。关于首例接受纳昔妥单抗治疗的病例。
Front Oncol. 2025 Jun 18;15:1520171. doi: 10.3389/fonc.2025.1520171. eCollection 2025.
3

本文引用的文献

1
MYCN protein stability is a better prognostic indicator in neuroblastoma.MYCN 蛋白稳定性是神经母细胞瘤预后的一个更好的指标。
BMC Pediatr. 2022 Jul 11;22(1):404. doi: 10.1186/s12887-022-03449-1.
2
High-Risk and Relapsed Neuroblastoma: Toward More Cures and Better Outcomes.高危神经母细胞瘤和复发性神经母细胞瘤:追求更高的治愈率和更好的预后。
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-13. doi: 10.1200/EDBK_349783.
3
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.《2022 年世卫组织神经内分泌肿瘤分类概述》。
Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in N-Myc-activated neuroblastoma.
植物生物碱高三尖杉酯碱靶向 N-Myc 激活神经母细胞瘤中的胰岛素瘤相关蛋白 1。
Cell Signal. 2023 Sep;109:110753. doi: 10.1016/j.cellsig.2023.110753. Epub 2023 Jun 9.
Endocr Pathol. 2022 Mar;33(1):115-154. doi: 10.1007/s12022-022-09708-2. Epub 2022 Mar 16.
4
INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists' View.INSM1:一种用于检测神经内分泌肿瘤的新型生物标志物——细胞病理学家的观点
Diagnostics (Basel). 2021 Nov 23;11(12):2172. doi: 10.3390/diagnostics11122172.
5
MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1.MI-773,一种MDM2/p53轴的破坏剂,通过下调INSM1在神经母细胞瘤中发挥抗癌作用。
Oncol Lett. 2021 Dec;22(6):838. doi: 10.3892/ol.2021.13099. Epub 2021 Oct 18.
6
Combined inhibition of Aurora-A and ATR kinase results in regression of -amplified neuroblastoma.极光激酶A(Aurora-A)和共济失调毛细血管扩张症和Rad3相关蛋白激酶(ATR)的联合抑制导致MYCN扩增的神经母细胞瘤消退。
Nat Cancer. 2021 Mar;2(3):312-326. doi: 10.1038/s43018-020-00171-8. Epub 2021 Feb 11.
7
MYCN Function in Neuroblastoma Development.MYCN在神经母细胞瘤发展中的作用。
Front Oncol. 2021 Jan 27;10:624079. doi: 10.3389/fonc.2020.624079. eCollection 2020.
8
A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma.一种基于启动子驱动的 INSM1 相关信号通路在神经母细胞瘤中的检测方法。
Cell Signal. 2020 Dec;76:109785. doi: 10.1016/j.cellsig.2020.109785. Epub 2020 Sep 20.
9
Inhibition of the ALDH18A1-MYCN positive feedback loop attenuates -amplified neuroblastoma growth.抑制 ALDH18A1-MYCN 正反馈环可减弱扩增的神经母细胞瘤生长。
Sci Transl Med. 2020 Feb 19;12(531). doi: 10.1126/scitranslmed.aax8694.
10
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface.通过 MYCN-PA2G4 结合界面抑制 MYCN 致癌信号。
Cancer Res. 2019 Nov 1;79(21):5652-5667. doi: 10.1158/0008-5472.CAN-19-1112. Epub 2019 Sep 9.